The chemical class known as SUSD4 Inhibitors represents a collection of compounds that target various biological pathways and processes associated with the Sushi Domain Containing 4 (SUSD4) protein. While SUSD4's exact functions are not fully delineated, it is understood to be involved in cellular activities like immune system regulation, cell adhesion, and possibly signal transduction. The inhibitors in this class are characterized by their ability to interact with these processes, aiming to modulate the activity of SUSD4. This modulation can occur through different mechanisms, each tailored to the unique nature of the target pathway.
For example, some inhibitors in this class focus on altering immune response pathways. Since SUSD4 is implicated in immune system modulation, these inhibitors can play a role in adjusting the immune system's interaction with cells expressing SUSD4. Other inhibitors target cell adhesion processes. Given the involvement of SUSD4 in these processes, affecting cell adhesion can consequently influence SUSD4's function. This approach is based on the understanding that manipulating the interaction between cells and their surrounding environment can have a downstream effect on proteins involved in these interactions. Moreover, some inhibitors in this class act on specific signaling pathways that are key to cell proliferation, differentiation, and survival. By modulating these pathways, these inhibitors can impact the cellular contexts in which SUSD4 operates, indirectly affecting its role. The development and categorization of SUSD4 Inhibitors are grounded in a comprehensive understanding of the protein's involvement in various cellular functions. The diversity within this chemical class stems from the variety of biological processes that SUSD4 is presumed to influence. Each inhibitor is designed to target a specific aspect of these processes, from immune response modulation to cell adhesion and signaling pathways. This targeted approach allows for a more precise interaction with the biological systems in which SUSD4 participates. The study and categorization of these inhibitors contribute significantly to the field of molecular biology, offering insights into the complex web of cellular interactions and functions. Through their targeted actions, SUSD4 Inhibitors serve as tools for exploring the diverse roles of SUSD4 in cellular physiology and the broader implications of its modulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, a calcium channel blocker, could possibly inhibit SUSD4 by affecting cell adhesion processes. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide, known for its immunomodulatory properties, could possibly inhibit SUSD4 by altering the immune response. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib, a tyrosine kinase inhibitor, could possibly inhibit SUSD4 by interfering with signaling pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an NF-kB pathway inhibitor, could possibly inhibit SUSD4 if it is involved in this signaling pathway. | ||||||
LY2109761 | 700874-71-1 | sc-396262 sc-396262A | 1 mg 5 mg | $89.00 $275.00 | 9 | |
Galunisertib, a TGF-beta pathway inhibitor, could possibly inhibit SUSD4's functions if linked to this pathway. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $102.00 $416.00 | 6 | |
Pirfenidone, known for anti-fibrotic properties, could possibly inhibit SUSD4 in cellular processes related to tissue remodeling. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Azathioprine, an immunosuppressive drug, could possibly inhibit SUSD4 by modifying immune responses. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Ibrutinib, a Bruton's tyrosine kinase inhibitor, could possibly inhibit SUSD4, especially in immune cell signaling pathways. | ||||||